Kardigan Shows Positive Ph 2a Danicamtiv Data in DCM at HFSA
29 Sep 2025 //
BUSINESSWIRE
MyoKardia Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy
09 Sep 2020 //
PRESS RELEASE
29 Sep 2025 //
BUSINESSWIRE
09 Sep 2020 //
PRESS RELEASE